M. Ruivard
Impact in
- Hematology top 2%
- Platelet Disorders and Treatments
- Iron Metabolism and Disorders
- Blood groups and transfusion
- Genetics top 5%
- Hemoglobinopathies and Related Disorders
- Blood disorders and treatments
Papers in
- Hematology 39
- Iron Metabolism and Disorders 17
- Blood groups and transfusion 13
- Platelet Disorders and Treatments 9
- Genetics 20
- Hemoglobinopathies and Related Disorders 16
- Journals
- British Journal of Haematology (3 papers)Medicine (3 papers)European Journal Of Haematology (2 papers)Blood (2 papers)Lupus (2 papers)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
M. Ruivard
87 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 92
- Hematology 606
- Genetics 316
- Rheumatology 335
- Internal Medicine 65
- Immunology 323
Countries citing papers authored by M. Ruivard
This map shows the geographic impact of M. Ruivard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ruivard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ruivard more than expected).
Fields of papers citing papers by M. Ruivard
This network shows the impact of papers produced by M. Ruivard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ruivard. The network helps show where M. Ruivard may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Ruivard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 2 | |
| 3 | Prognostic Factors and Treatment Efficacy in Spinal Cord Sarcoidosis: An Observational Cohort With Long-term Follow-up. | 2022 | 1 |
| 4 | 2021 | 1 | |
| 5 | 2021 | 19 | |
| 6 | 2021 | 22 | |
| 7 | 2021 | 5 | |
| 8 | 2021 | 6 | |
| 9 | efficacy and tolerance of tnf alpha inhibitor treatment in cardiac sarcoidosis | 2018 | 1 |
| 10 | Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trial. | 2017 | 18 |
| 11 | 2013 | 52 | |
| 12 | 2011 | 26 | |
| 13 | 2011 | 1 | |
| 14 | 2009 | 72 | |
| 15 | 2007 | 1 | |
| 16 | 2007 | 57 | |
| 17 | 2006 | 35 | |
| 18 | 2004 | 3 | |
| 19 | 2003 | 8 | |
| 20 | 2003 | 29 |
About M. Ruivard
M. Ruivard is a scholar working on Hematology, Genetics, Internal Medicine, Physiology and Rheumatology, having authored 98 papers that have together received 1.6k indexed citations. Recurring topics across this work include Iron Metabolism and Disorders (17 papers), Hemoglobinopathies and Related Disorders (16 papers), Sarcoidosis and Beryllium Toxicity Research (13 papers), Blood groups and transfusion (13 papers), Vasculitis and related conditions (11 papers), Platelet Disorders and Treatments (9 papers), Trace Elements in Health (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). The work is most often cited by research in Hematology (606 citations), Genetics (316 citations), Rheumatology (335 citations), Internal Medicine (65 citations) and Immunology (323 citations). M. Ruivard has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include G. Le Guenno, V. Rieu, Andrzej Mazur, Lionel Galicier, Marc Michel, Luc Mouthon, Pascal Cohen, P. Sève, Olivier Hermine and Philippe Bierling. Their work appears in journals such as British Journal of Haematology, Medicine, European Journal Of Haematology, Blood and Lupus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.